gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
Published 11 years ago • 331 plays • Length 10:37Download video MP4
Download video MP3
Similar videos
-
18:51
gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
13:05
gracecast-009_lung-cancer_the abc's of bac
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
6:00
immunotherapy for patients with driver mutation - lung cancer video library
-
1:47
alk rearrangements: what are they, and who has them?
-
9:18
gracecast - treatment options for metastatic nsclc
-
2:07
grace targeted therapies lung cancer 2021 - ros1 & alk treatments transform neuroendocrine tumor
-
6:49
can we improve on xalkori? new agents for patients with an alk-1 rearrangement
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
5:42
gracecast - lcvl- what are the options after a patient with an alk-positive advanced nsclc develops
-
25:07
2020 ttf alk session - lin - tkis for ros1
-
5:35
gracecast - what is the optimal treatment for patients with advanced nsclc and a braf-v600e mutation
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
12:46
gracecast-086_lung-cancer_q&a with drs. solomon and camidge on alk inhibition for advanced nsclc